California’s Stem Cell Agency Announces International Collaborations and $69 Million in New Research Funding The California Institute for Regenerative Medicine announced its first ever collaboratively funded research projects with China and the federal government of Australia, a new project with Germany, plus $69 million for research to help develop therapies for 15 diseases in its latest round of funding. [California Institute for Regenerative Medicine] Press Release Karolinska University Hospital and GE Healthcare Collaborate to Advance Technologies for Cell Therapy Karolinska University Hospital Sweden and General Electric (GE) Healthcare Life Sciences announced a joint research collaboration to drive advances in technologies and workflows for use in the rapidly emerging field of cell therapy. [General Electric Company] Press Release IntelliCell BioSciences Announces Collaborative Agreement with the University of Florida on Stem Cell and Tissue Repair Research IntelliCell BioSciences, Inc. announced that it has entered a sponsored research agreement with the Institute for Cell Engineering and Regenerative Medicine at the University of Florida. [PR Newswire] Press Release Alnylam and PBL Sign License Agreement for Baulcombe & Hamilton RNA Interference Patent Alnylam Pharmaceuticals, Inc. and Plant Bioscience Limited (PBL) announced that they have entered into a licensing agreement. PBL has granted Alnylam a world-wide, non-exclusive license to the Baulcombe patent for use in the field of human therapeutics. [Alnylam Pharmaceuticals, Inc.] Press Release Maryland Stem Cell Research Commission Funds 40 New Proposals in FY 2012 The board of directors of the Maryland Technology Development Corporation approved the Commission’s recommendation to fund 40 new proposals with the Maryland Stem Cell Research Fund’s $12.4 million FY 2012 budget. [Maryland Stem Cell Research Fund] Press Release UC San Diego Researchers Receive New CIRM Funding Five scientists from the University of California (UC), San Diego and its School of Medicine have been awarded almost $12 million in new grants from the California Institute for Regenerative Medicine (CIRM) to conduct stem cell-based research into regenerating spinal cord injuries, repairing gene mutations that cause amyotrophic lateral sclerosis and finding new drugs to treat heart failure and Alzheimer’s disease. [University of California, San Diego Health System] Press Release UCI Stem Cell Researcher to Receive $4.8 Million in State Funding A University of California, Irvine (UCI) immunologist will receive $4.8 million to create a new line of neural stem cells that can be used to treat multiple sclerosis. [University of California, Irvine] Press Release Cellectis Stem Cells Proudly Announces the Launch of the World’s Very First Human iPS Cell-Derived Hepatocyte Product Cellectis stem cells announced the launch of a human induced pluripotent stem (iPS) cell derived hepatocyte product, hiPS-HEPTM. [Cellectis Group] Press Release RetroSense Therapeutics Completes Pre-IND Meeting for RST-001 RetroSense Therapeutics announced completion of a pre-Investigational New Drug (IND) meeting with the Center for Biological Evaluation and Research division of the FDA regarding RetroSense’s lead biologic, RST-001 for vision restoration in retinal degenerative conditions. [Business Wire] Press Release KRIBB to Initiate Research Infrastructure for Xeno-Transplantation R&D The Korea Research Institute of Bioscience and Biotechnology (KRIBB) opened the Xenotransplantation Bio-resources Building of the Korea National Primate Research Center at the Ochang Campus. The new building will support projects such as xeno-transplantation research through the combined efforts of industrial, academic, and research institutes, along with the existing resources of the Korea National Primate Research Center. [Korea Research Institute of Bioscience and Biotechnology] Press Release |